AltRx vs FuturHealth (2026): Budget GLP-1 Compared
AltRx and FuturHealth both compete in the budget-to-mid-tier GLP-1 space, but their approaches differ. AltRx leads with a low advertised entry price ($89/mo promotional) and BNPL options. FuturHealth leads with formulary breadth, brand-name GLP-1 access, and an oral GLP-1 pill option.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
AltRx is a compounded GLP-1 clinic that advertises one of the lowest entry prices in the market — $89/mo for compounded semaglutide on a promotional first-month basis. Standard pricing starts at $159/mo. The platform also offers brand-name Zepbound, Mounjaro, Wegovy, and Ozempic for patients who want FDA-approved drugs. Buy Now Pay Later options are available, which is a practical differentiator for patients managing upfront costs.
FuturHealth is a broader GLP-1 platform with a more established track record. It offers compounded semaglutide and tirzepatide, brand-name GLP-1, and an oral GLP-1 pill option — one of the few platforms to offer all three delivery formats. FuturHealth's pricing is competitive at the mid-tier but higher than AltRx's promotional rate. The oral pill option is a meaningful differentiator for patients who are needle-averse.
AltRx
Budget-first compounded GLP-1 clinic with a low advertised entry price ($89/mo semaglutide), transparent pricing, and optional brand-name GLP-1 access.
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Side-by-Side Comparison
| Attribute | AltRx | FuturHealth |
|---|---|---|
| Program Fee | Included in monthly plan | Included in monthly plan |
| Medication From | From $89 – $279/mo | From $198 – $395/mo |
| Editor Score | 4.3 / 5 | 4.0 / 5 |
| Primary Category | GLP-1 Weight Loss | GLP-1 Weight Loss |
| FDA Brand-Name Access | Zepbound, Mounjaro, Wegovy, Ozempic | Wegovy, Zepbound, Ozempic, Mounjaro |
| Compounded Options | 2 compounds | 1 compounds |
| Adjacent Categories | GLP-1 Weight Loss | GLP-1 Weight Loss |
The Verdict
AltRx wins on advertised entry price and BNPL flexibility. FuturHealth wins on formulary breadth, the oral GLP-1 pill option, and brand-name access depth. If price is the primary driver and you're comfortable with injectable compounded GLP-1, AltRx is the lower-cost entry. If you want the widest format and formulary choice, FuturHealth is the stronger platform.
Frequently Asked Questions
Is AltRx's $89/mo price real?
The $89/mo rate is a promotional first-month price for compounded semaglutide. Standard pricing starts at $159/mo. FuturHealth's compounded semaglutide pricing starts at a comparable level without a promotional tier.
Does AltRx offer an oral GLP-1 pill?
No, AltRx offers injectable compounded semaglutide and tirzepatide plus brand-name GLP-1. FuturHealth is one of the few platforms to offer an oral GLP-1 pill option.
Which has better brand-name GLP-1 access?
Both offer brand-name Wegovy, Zepbound, Ozempic, and Mounjaro. FuturHealth has a more established track record for brand-name access and insurance navigation.